Global Medical Office Dialogues Hosted by Frank Maddux 

Global Medical Office Dialogues is Fresenius Medical Care's signature medical video magazine, dedicated to excellence in storytelling that brings medical-scientific knowledge to life. Produced by the Global Medical Office and hosted by Frank Maddux, MD, Global Chief Medical Officer, our in-depth interviews feature diverse global voices representing some of the leading minds at the intersection of science, medicine, and current events.



Published: September 29, 2021

Expanding our scientific understanding of the effectiveness and safety of interventions for individuals with End Stage Kidney Disease is an important goal of researchers. In this episode of Dialogues, we’ll talk with Dr. Linda Ficociello and Dr. Anke Winter, two Fresenius Medical Care experts in epidemiology and research. They discuss ways Real World Evidence can complement existing research in gaining new and valuable insights that improve kidney disease care.



Published: September 15, 2021

Improving vascular access care is key to improving outcomes for people receiving hemodialysis.  In this edition of Global Medical Office Dialogues our guest is Dr. Walead Latif, an interventional nephrologist and vascular access care expert. A Medical Director at Azura Vascular Care in the United States, Dr. Latif weighs in on improving patient outcomes by addressing challenges and opportunities in vascular access.



Published: September 01, 2021

Improving access to kidney transplantation on a worldwide basis is a vital next step for global healthcare. In this episode of Dialogues, transplant expert, Dr. Ben Hippen, MD, FASN, FAST, Senior Vice President of Transplant Medicine for Fresenius Medical Care, discusses the challenges and opportunities facing global transplantation and why transplantation remains a vital therapy option for people living with advanced kidney disease.



Published: July 07, 2021

In this episode of Dialogues, we talk with two of the world’s leading authorities on chronic kidney disease, Drs. Bernard Canaud and Allan Collins, Senior Chief Scientists at Fresenius Medical Care. We discuss how addressing common, manageable complications through personalized renal replacement therapy can improve cardiac outcomes in hemodialysis patients.



Published: June 23, 2021

Nephrology has been under-represented in clinical research, even as rapid progress in gene sequencing and analysis has led to precision medicine advances in other medical areas like oncology and cardiology. Ali Gharavi, MD, Chief of the Division of Nephrology at Columbia University Irving Medical Center and Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons, discusses how genomic and phenotypic research can help scientists better understand how genetic variations in patients with chronic kidney disease can lead to more precise diagnoses and therapies that help improve outcomes by individualizing care.



Published: June 09, 2021

The evidence for genetic drivers in kidney diseases is substantial, but much larger data sets will be needed to untangle the complex interactions that lead to kidney injury. Kurt Mussina, President of Frenova Renal Research, talks about Frenova’s efforts to develop the largest renal-focused genomic registry in the world. Containing genetic sequencing data from chronic kidney disease patients around the globe, data from the registry will be used by researchers to improve understanding of kidney disease. 



Published: May 12, 2021

In part two of our exploration of Food Is Medicine, veteran health and wellness expert Allison Hess, Vice President of Health Innovations at Geisinger, discusses the company’s successful Fresh Foods Farmacy.  By providing fresh, healthy food to those most in need, Allison and team are shining a light on the vital role healthy foods play in improving patient outcomes.



Published: April 28, 2021

Dr. Amir Sapkota, professor at the University of Maryland, talks about the effects climate change has on health outcomes.  He discusses the relationships between frequency of extreme events, changes in plant phenology, and increased risk of respiratory diseases.  Dr. Sapkota is developing public health strategies to combat the effects of a changing climate.



Published: April 14, 2021

Biochemist Nadja Grobe, supervisor of lab research at the Renal Research Institute, discusses how metabolomic signatures can be used to deliver more personal, precise care for patients living with kidney disease.  By learning from these unique biomarkers, researchers are at the forefront of developing the future of personalized medicine.



Published: March 31, 2021

In this episode of Dialogues, we continue our look at Translating Science Into Medicine by talking with Dr. Doris Fuertinger, Director of Biomathematical Modeling and Simulation at Fresenius Medical Care, and a pioneer in the concept of virtual clinical trials.  Dr. Fuertinger and her team are spearheading new techniques using complex mathematics and real-life data to create patient Avatars that can help predict an individual’s physiological response to a certain treatment.  These realistic simulations of clinical trials can help overcome the limitations of traditional approaches and lead to new improvements in patient outcomes.



Published: March 17, 2021

We talk with Dr. Peter Kotanko, research director at RRI, the Renal Research Institute, about the effects of extreme climate events on vulnerable patient populations. Dr. Kotanko co-authored an investigation  exploring the association between extreme heat events, hospital admissions, and mortality among patients with kidney failure.



Published: March 3, 2021

In part three of our exploration into Translating Science into Medicine, we talk with Hanjie Zhang, biostatistician at RRI, the Renal Research Institute, and an expert in artificial intelligence and machine learning.  Scientists at RRI have created a mobile application using vascular access images to identify and classify aneurysms that may pose a risk to patients.  By quickly analyzing smartphone images taken by a caregiver, the app classifies the presence or severity of an aneurysm in the patient’s vascular access. This app is an example of how artificial intelligence can help recognize patterns in data, automatically flag potential problems, and improve personalized patient care.



Published: February 17, 2021

Episode two of our special look at Translating Science Into Medicine.  Analytics expert, Dr. Len Usvyat talks about his team’s work in using advanced analytics to support clinical decision-making.  His team is at the forefront of turning the aspirations of AI into applied medicine.  By leveraging big data to accelerate AI solutions for kidney disease, researchers, data scientists, and practitioners are developing clinical tools that enhance patient care.



Published: February 3, 2021

Translating Science into medicine episode one with Dr. Peter Kotanko, Reserach Director of RRI (The Renal Research Institute). Translational research is an effort to build on scientific advances to create new therapies and diagnostics that advance patient care. A discussion on the quest to reimagine the future of kidney care by both seeing and focusing on new and evolving science that can benefit patients.



Published: December 10, 2020

Nephrologist and kidney disease expert, Dr. Dugan Maddux, explores the impact of food insecurity and healthy eating on patients living with chronic kidney disease, and the importance of addressing social determinants of healthcare outcomes. 



Published: June 10, 2020

Diversity expert and author, Lenora Billings-Harris, talks with Dr. Frank Maddux about racism and unintended bias in healthcare. Lenora was a keynote speaker for one of Fresenius Medical Care's Medical Office Live broadcast series on the same topic and talks about racism, unintended bias in healthcare, and how to have meaningful dialogue around these topics. 



Published: June 10, 2020

The inaugural interview for the new Global Medical Office Dialogues video series is with William Kaelin Jr., MD, Sydney Farber Professor at Harvard Medical School, Dana Farber, and Brigham and Women's Hospital in the United States, and winner of the 2019 Nobel Prize for his research with two others regarding how cells sense and adapt to oxygen availability with implications for anemia and chronic kidney disease care. 

About the Host 

Global Medical Office Dialogues is hosted by Frank Maddux, MD, Global Chief Medical Officer for Fresenius Medical Care and Member of the Management Board. Physician, expert nephrologist, technology entrepreneur, and health care executive, Dr. Maddux created the company's medical office broadcast network, and the Medical Office Live global broadcast series for physicians and clinicians. He is editor in chief for the Fresenius Medical Care Annual Medical Report and is a Fellow of the American College of Physicians. An alumnus of Vanderbilt University, Dr. Maddux holds his doctorate in medicine from the University of North Carolina at Chapel Hill, where he holds a faculty appointment as clinical associate professor. His writings have appeared in leading medical journals, and his pioneering healthcare information technology innovations are part of the permanent collection of the National Museum of American History at the Smithsonian Institution.